Skip to Content
Merck
CN

B0500000

Benzathine benzylpenicillin

European Pharmacopoeia (EP) Reference Standard

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C32H36N4O8S2 · C16H20N2
CAS Number:
Molecular Weight:
909.12
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

pharmaceutical primary standard

API family

penicillin & derivatives

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

S6[C@H]7N([C@H](C6(C)C)C(=O)[O-])C(=O)[C@H]7NC(=O)Cc8ccccc8.S3[C@H]4N([C@H](C3(C)C)C(=O)[O-])C(=O)[C@H]4NC(=O)Cc5ccccc5.[N+H2](CC[N+H2]Cc2ccccc2)Cc1ccccc1

InChI

1S/2C16H18N2O4S.C16H20N2/c2*1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;1-3-7-15(8-4-1)13-17-11-12-18-14-16-9-5-2-6-10-16/h2*3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);1-10,17-18H,11-14H2/t2*11-,12+,14-;/m11./s1

InChI key

BVGLIYRKPOITBQ-ANPZCEIESA-N

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Benzathine benzylpenicillin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.


pictograms

Health hazardExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Resp. Sens. 1

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

涉药品监管产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



WHO Model Prescribing Information: Drugs Used in Bacterial Infections
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (2001)
Treatment of late-stage syphilis.
Aram S A van Brussel et al.
JAMA, 313(9), 968-969 (2015-03-04)
Ahmadreza Moradi et al.
American journal of ophthalmology, 159(2), 334-343 (2014-12-03)
To describe the clinical outcomes of ocular syphilis. Retrospective chart review. The charts of patients with ocular syphilis (regardless of human immunodeficiency virus [HIV] status) seen in a uveitis referral center between 1984 and 2014 were reviewed. The study included



Global Trade Item Number

SKUGTIN
B050000004061838457431